Pediatric Emergency Care Applied Research Network Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT01197417
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pediatric Emergency Care Applied Research Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 3)

Brain Injuries (Phase 3)

Brain Injuries, Traumatic (Phase 3)

Hemorrhage (Phase 3)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3